Pediatrix Medical (MD) Debt to Equity (2009 - 2026)

Pediatrix Medical has disclosed Debt to Equity across 18 years of filings, most recently posting $0.67 for Q1 2026.

• In Q1 2026, Debt to Equity fell 13.38% year-over-year to $0.67; the TTM figure through Mar 2026 stood at $0.67 (down 13.38% YoY), while the FY2025 annual figure was $0.69, down 14.56% from the prior year.
• Debt to Equity slipped to $0.67 in Q1 2026, from $0.69 in the prior quarter.
• Over the last five years, Debt to Equity for MD reached as high as $0.89 in Q2 2024 and fell as low as $0.06 in Q2 2023.
• The 5-year median for Debt to Equity is $0.68 (2025), against an average of $0.53.
• The widest YoY moves for Debt to Equity: up 26042.66% in 2022, down 89.2% in 2022.
• A 5-year view of Debt to Equity shows it stood at $0.73 in 2022, then climbed by 2.75% to $0.75 in 2023, then gained by 8.25% to $0.81 in 2024, then slipped by 14.56% to $0.69 in 2025, then retreated by 2.53% to $0.67 in 2026.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.67, $0.69, and $0.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.